355 results
Page 10 of 18
S-4/A
EX-10.6
rsr96ni260zx
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.3
twmdwrgg q7urony6ts
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.45
1z7tft4ar2cgcxukqit
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-10.1
t27k62 qnmox1wt
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-10.1
rblpvp
1 Nov 18
Business combination disclosure
5:00pm
S-8
31ca1gav7bkczg1g
9 Aug 18
Registration of securities for employees
5:29pm
8-K
EX-2.1
kvh ayrxhi
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.3
gy5eonoglz
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-3.1
0g76vhv
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.4
flgrk2734tiot 76n
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.4
4tkcrqk679dumrg7y hh
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.2
5gio 4tzfhr9hm
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
id5dkojdxvdbm0r44
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.2
ws03ek2etco0col9w
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.4
bs0p6t7irjpp fw6
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.4
iu31drg
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.3
p92lu
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
uo9ijn2uz inzp
9 Aug 18
Business combination disclosure
5:17pm